Track topics on Twitter Track topics that are important to you
Shares of AnaptysBio Inc. are up nearly 24% year-to-date, way ahead of the iShares NASDAQ Biotechnology Index, which has gained just 2.77% during the same time frame. Given the fact that AnaptysBio has couple of announcements up its sleeve, it's worth keeping an eye on this stock.
Original Article: In The Spotlight: AnaptysBioNEXT ARTICLE
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...